测试版
试验雷达 AI
临床试验 NCT07493863 针对Ergonomics,Virtual Reality Headset,虚拟现实,内镜检查目前招募中。请查看临床试验雷达卡片视图和 AI 发现工具了解所有详情,或在此提出任何问题。
一个试验符合筛选条件
卡片视图

Feasibility and Ergonomic Impact of A Virtual Reality Headset in Endoscopic Procedures 140 虚拟

招募中
临床试验详情主要以英语提供。然而,试验雷达 AI可以提供帮助!只需点击“试验详解”即可查看和讨论您选择的语言的试验信息。
临床试验NCT07493863是一项针对Ergonomics,Virtual Reality Headset,虚拟现实,内镜检查干预性研究试验,目前试验状态为招募中。试验始于2026年3月10日,计划招募140名患者。该研究由The Cleveland Clinic主导,预计于2026年12月1日完成。试验数据来源于ClinicalTrials.gov,最后更新时间为2026年3月25日
简要概括
The purpose of this study is to assess the feasibility of using a virtual reality headset (VRH) during endoscopy and its impact on the endoscopist ergonomics. We will use the Apple Vision Pro during approximately 140 endoscopic procedures during which ergonomics will be assessed.
官方标题

Feasibility and Ergonomic Impact of A Virtual Reality Headset in Endoscopic Procedures

疾病
ErgonomicsVirtual Reality Headset虚拟现实内镜检查
其他研究标识符
  • 26-072
NCT编号
实际开始日期
2026-03-10
最近更新发布
2026-03-25
预计完成日期
2026-12
计划入组人数
140
研究类型
干预性研究
试验分期 (阶段)
不适用
试验状态
招募中
关键词
ergonomics
virtual reality
virtual reality headset
endoscopy
主要目的
预防
分配方式
非随机
干预模型
序贯设计
盲法
无(开放性试验)
试验组/干预措施
参与者组/试验组干预措施/治疗方法
阳性对照NonVRH
Endoscopic procedure without virtual reality headset (VRH)
MYSELF checklist
A preprocedural timeout to improve ergonomics.
阳性对照VRH
Endoscopic procedure completed with virtual reality headset (VRH)
虚拟现实头戴设备
Use of the virtual reality headset during endoscopic procedures.
MYSELF checklist
A preprocedural timeout to improve ergonomics.
主要终点
结果指标度量标准描述时间框架
Risk Reduction of endoscopy related musculoskeletal injury by VRH as assessed by rapid entire body assessment (REBA) score.
The REBA score is an ergonomic assessment tool used to identify potential risks of musculoskeletal disorders in the workplace by evaluating posture and movements. The score ranges from 0-15 with 0 being the lowest risk and 15 being the highest risk. A two point decrease pre-intervention will be considered significant.
From the start until the end of an endoscopic procedure.
次要终点
结果指标度量标准描述时间框架
Endoscopist experience with VRH assess via subjective survey scored on a 5-point Likert scale.
The survey includes six questions on ergonomics, technical feasibility, visual clarity, workflow, mental demands, and overall experience. Each question is scored 1-5 with the higher score being outcome.
From the start until the end of an endoscopic procedure.
Risk reduction of endoscopic related musculoskeletal injury in specific subgroups (colonoscopy, EUS, ERCP) by VRH as assessed by rapid entire body assessment (REBA) score.
The REBA score is an ergonomic assessment tool used to identify potential risks of musculoskeletal disorders in the workplace by evaluating posture and movements. The score ranges from 0-15 with 0 being the lowest risk and 15 being the highest risk. A two point decrease pre-intervention will be considered significant.
From the start until the end of an endoscopic procedure.
risk reduction of endoscopy related musculoskeletal injury due to pre-procedural checklist as assessed by rapid entire body assessment (REBA) score.
The REBA score is an ergonomic assessment tool used to identify potential risks of musculoskeletal disorders in the workplace by evaluating posture and movements. The score ranges from 0-15 with 0 being the lowest risk and 15 being the highest risk. A two point decrease pre-intervention will be considered significant.
From the start until the end of an endoscopic procedure.
参与助手
资格标准

适龄参与研究
儿童, 成人, 老年人
适龄性别
全部
接受健康志愿者
  • Endoscopist: endoscopist at Cleveland Clinic Weston who consent to participate in the study and are performing either colonoscopy, EUS, or ERCP.
  • Patient: patient undergoing colonoscopy, EUS, or ERCP

  • Exclude the following procedures: Device-assisted colonoscopy (e.g.- double balloon, pathfinder, etc)
  • ERCP in native papilla
  • Cholangioscopy
  • Therapeutic EUS procedures (FNA/FNB, Stent Placement)
  • Planned Mucosal Resection of Polyps > 20 mm
  • Inpatient procedures
  • Aborted procedures
The Cleveland Clinic logoThe Cleveland Clinic
研究责任方
Shah,Tilak, 主要研究者, Medical Director, National Pancreas Center of Excellence, Advanced Therapeutic Endoscopy, The Cleveland Clinic
没有联系数据。
1 位于 1 个国家/地区的研究中心

Florida

Cleveland Clinic Weston, Weston, Florida, 33331, United States
Tilak Shah, MD, 联系人, 877.463.2010, [email protected]
招募中